Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.87
-0.0900-4.59%
Post-market: 1.870.0001+0.01%19:53 EDT
Volume:6.24M
Turnover:11.80M
Market Cap:613.15M
PE:-8.29
High:1.96
Open:1.95
Low:1.86
Close:1.96
52wk High:2.73
52wk Low:0.5700
Shares:327.89M
Float Shares:306.73M
Volume Ratio:0.41
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2257
EPS(LYR):-0.2260
ROE:-776.89%
ROA:-63.10%
PB:-50.40
PE(LYR):-8.27

Loading ...

Ocugen Inc. Stock Slides 7.5%, Underperforms Market

Dow Jones
·
Nov 14, 2025

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Nov 12, 2025

Noble Financial Reaffirms Their Buy Rating on Ocugen (OCGN)

TIPRANKS
·
Nov 08, 2025

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Nov 07, 2025

Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses

TIPRANKS
·
Nov 06, 2025

Ocugen Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Progress in Gene Therapy and Global Partnerships

Earnings Call
·
Nov 06, 2025

Ocugen (OCGN) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 06, 2025

Ocugen Q3 Sales $1.752M Beat $550.000K Estimate

Benzinga
·
Nov 05, 2025

BRIEF-Ocugen Q3 Profit From Operations USD -17.625 Million

Reuters
·
Nov 05, 2025

Ocugen Inc: Expect Our Current Cash Position Provides Sufficient Runway to Operate Through 2Q 2026

THOMSON REUTERS
·
Nov 05, 2025

Ocugen Inc: to Release Full Data From Phase 2 Clinical Trial of Ocu410 in Q1 of 2026 and Begin Phase 3 in 2026

THOMSON REUTERS
·
Nov 05, 2025

Ocugen Q3 Net Income USD -20.051 Million

THOMSON REUTERS
·
Nov 05, 2025

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 05, 2025

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Nov 04, 2025

Ocugen Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Ocugen Inc. Stock Rallies 5.4%, Outperforms Market

Dow Jones
·
Nov 01, 2025

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Oct 28, 2025

Ocugen’s OCU200 Study: A Potential Game-Changer for Diabetic Macular Edema

TIPRANKS
·
Oct 28, 2025

Ocugen Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Oct 24, 2025

Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results

GlobeNewswire
·
Oct 23, 2025